Liraglutide Injection, 18 mg/3 mL (6 mg/mL) recall — FDA D-0541-2026
Presence of particulate matter: a white thread-like structure in the cartridge
Complete FDA and NHTSA recall records dated in May 2026.
These records include useful source details for the selected month.
Presence of particulate matter: a white thread-like structure in the cartridge
CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit
Labeling: Label Mix-Up: Atomoxetine HCl 25mg Capsule incorrectly labeled as Atomoxetine HCl 10mg Capsule.
Potential contamination with Salmonella.
Potential contamination with Salmonella.
Deviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen and possible C. Botulinum concerns.
Product was made with milk powder recalled by the supplier due to Salmonella contamination.
Product was made with milk powder recalled by the supplier due to Salmonella contamination.
Product was made with milk powder recalled by the supplier due to Salmonella contamination.
Potential contamination with Salmonella.
Potential contamination with Salmonella.
Deviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen and possible C. Botulinum concerns.
Product was made with milk powder recalled by the supplier due to Salmonella contamination.
Product was made with milk powder recalled by the supplier due to Salmonella contamination.
Product was made with milk powder recalled by the supplier due to Salmonella contamination.
Deviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen contamination and possible C. Botulinum concerns.
Deviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen and possible C. Botulinum concerns.
Deviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen and possible C. Botulinum concerns.
Potential contamination with Salmonella.
Deviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen and possible C. Botulinum concerns.
Deviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen and possible C. Botulinum concerns.
Foreign object: black particulate matter
Deviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen and possible C. Botulinum concerns.
Deviations from current Good Manufacturing Practices (cGMP) that could lead to bacterial pathogen and possible C. Botulinum concerns.
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.